Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters

In a new study, researchers assessed the impact of pre-existing immunity against SARS-CoV-2 acquired by previous infections (PI) or COVID-19 vaccination on the transmission of SARS-CoV-2 variants of concern such as Delta and Omicron.

Cross-variant protection against SARS-CoV-2 infection in hamsters

A Heterologous Challenge Rescues the Attenuated Immunogenicity of

How Protective are Antibodies to SARS-CoV-2, the Main Weapon of

Cross protection to SARS-CoV-2 variants in hamsters with naturally

Infection- or vaccine mediated immunity reduces SARS-CoV-2

Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry

Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities

Frontiers SARS-CoV-2 Variants, Vaccines, and Host Immunity

Viruses, Free Full-Text

Pathogens, Free Full-Text

A Selective SARS-CoV-2 Host-Directed Antiviral Targeting Stress

Post-acute sequelae of COVID-19: A metabolic perspective